Ki-67 anticorps (AA 2293-2478)
Aperçu rapide pour Ki-67 anticorps (AA 2293-2478) (ABIN7872446)
Antigène
Voir toutes Ki-67 (MKI67) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- AA 2293-2478
-
Fonction
- Ki-67 Antibody (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogène
- A recombinant human Ki67 protein fragment (within amino acids 2293-2478) was used as the immunogen for the Ki-67 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the Ki-67 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Ki-67 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Ki-67 (MKI67) (Antigen Identified By Monoclonal Antibody Ki-67 (MKI67))
-
Autre désignation
- Ki-67
-
Sujet
- Ki-67 antigen is a nuclear, non-histone protein that is present in all stages of the cell cycle except G0. This characteristic makes Ki-67 an excellent marker for proliferating cells and is commonly used as one of the prognostic factors in cancer studies. A correlation has been demonstrated between Ki-67 index and the histo-pathological grade of neoplasms. Assessment of Ki-67 expression in renal and ureter tumors shows a correlation between tumor proliferation and disease progression, thus making it possible to differentiate high-risk patients. Ki-67 expression may also prove to be important for distinguishing between malignant and benign peripheral nerve sheath tumors. Ki-67 labeling index has been shown to be a prognostic marker in a number of neoplasms including grade II astrocytoma, oligodendroglioma, colon carcinoma, and breast carcinoma. In general, Ki-67 is a good marker of proliferating cell populations.
-
UniProt
- P46013
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-